Epidemiology of stroke in Guadeloupe and role of sickle cell trait;Epidemiologie des accidents vasculaires cerebraux en Guadeloupe et role du trait drepanocytaire

Revue Neurologique

Volumn 155, Issue 5, 1999, Pages 351-356

  Lannuzel, A ^a,e   Salmon, V ^a   Mevel G ^b   Malpote, E ^c   Rabier, R ^d   Caparros Lefebvre, D ^a  

^a Service de Neurologie   (Guadeloupe)

^b Serv des Urgences Médicales   (Guadeloupe)

^c Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

^d INSEE ^*  (Guadeloupe)

^e Ctr Hosp Univ de Pointe a Pitre   (Guadeloupe)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIDEMIOLOGY; ERYTHROCYTE DISORDER; FEMALE; GUADELOUPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SICKLE CELL TRAIT; STROKE; VASCULAR ENDOTHELIUM; AGE DISTRIBUTION; BRAIN; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPARATIVE STUDY; MIDDLE AGED; PROSPECTIVE STUDY; SEX RATIO; VASCULARIZATION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; GUADELOUPE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SICKLE CELL TRAIT;

EID: 0033129262     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ADAMS RJ (1995) Sickle cell disease and stroke, J Child Neurol, 10: 75-76.
2. AMSTRONG F.D., THOMPSON R.J., WINFRED W., ZIMMERMAN R., PEGELOW C.H., MILLER S., MOSER F., BELLO J., HURTIG A., VASS K. for the Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease (1996), 97: 864-870.
3. BALKARAN B., CHAR G., MORRIS J.S., THOMAS P.W., SERJEANT B.E., SERJEANT G.R. (1992). Stroke in a cohort of patients with homozygotous sickle cell disease. J Pediatr, 120: 360-366.
4. BAZÉLY P., SALINES G., LE TOULLEC A. (1994). Causes de mort aux Antilles-Guyane et en métropole. Étude par taux comparatif. In Hatton F et Bazély P (eds), Mortalité en Antilles-Guyane, Les Éditions INSERM, Paris 55-69.
5. BERTRAND E. (1985). L'hypertension artérielle, problème de santé publique en Afrique Noire. Bull Acad Natle Med, 5: 623-631.
6. BOGOUSSLAVSKY J., VAN MELLE G., REGLI F. (1988). The Lausanne Stroke Registry: analysis of 1000 consecutive patients with stroke. Stroke, 21: 1083-1092.
7. BUNN H.F. et FORGET B.G. (1986). Sickle cell disease. Clinical and epidemiological aspects. In Bunn HF et Forget BG (eds), Hemoglobin: molecular, genetic and clinical aspects, WB Saunders Company, 502-550.
8. CHAP T. (1992). Maximum likelihood estimation for multi-parameter models. In Owen DB (ed), Statistics: Textbooks and Monographs. Fundamentals of biostatistical inference, Marcel Dekker, New York, Basel, 87-120.
9. COSTAGLIOLA D., DELAUNAY C., MOUTET J.P. (1991). The prevalence of diabetes mellitus in the adult population of Guadeloupe as estimated by history or fasting hyperglycemia. Diabetes Res Clin Pract, 12: 209-216.
10. FAILDE R.H., BALKAU B., COSTAGLIONA D., MOUTETE J.P., GABRIEL J.P., ESCHWEGE E. (1996). Arterial hypertension in the adult population of Guadeloupe, and associated factors in subjects of african origin. Rev Epidem et Santé Publ, 44: 417-426.
11. FRENCH J.A., KENNY D., SCOTT J.P., HOFFMAN R.G., WOOD J.D., HUDEZT A.G., HILLERY C.A. (1997). Mechanisms of stroke in Sickle Cell Disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. Blood, 12: 4591-4599.
12. HART R.G. et KANTER M.C. (1990). Hematologic disorders and ischemic stroke. A selective review. Stroke, 21:1111-1121.
13. HOUSTON P.E., RANA S., SEKHSARIA S., PERLIN E., KYUNG SOOK K., CASTRO O.L. (1997) Homocysteine in Sickle Cell Disease: Relationship to stroke. Am J Med, 103: 192-196.
14. s haplotypes, α-globin gene status, and hematological data of sickle cell disease patients in Guadeloupe (F.W.I.). Hemoglobin, 20: 63-74.
15. KÉCLARD L., ROMANA M., LAVOCAT E., SAINT-MARTIN C., BERCHEL C., MÉRAULT G. (1997). Sickle cell disorder, β-globin gene cluster haplotypes and α-thalassemia in neonates and adults from Guadeloupe. Am J Hematol 55: 24-27.
16. MÉRAULT G., DIARA J.P., DE CAUNES F. (1991). Dépistage néonatal et prise en charge coordonnée de la drépanocytose en Guadeloupe. In Galacteros F, Dormont S (eds) Drépanocytose et Santé Publique, Les Éditions INSERM, Paris 31-44.
17. MOULIN T., TATU L., CREPIN-LEBLOND T., CHAVOT D., BERGES S., RUMBACH T. (1997). The Besancon Stroke Registry: an acute stroke registry of 2,500 consecutive patients. Eur Neurol, 38: 10-20.
18. NAGEL R.L., ROTH E.F. (1989). Malaria and red cell genetic defects. Blood, 74: 1213-1221.
19. NAGEL R.L., RANNEY H.M. (1990). Genetic epidemiology of structural mutations of the β-globin gene. Semin Hematol, 27: 342-359.
20. National Institute of Neurological Disorders and Stroke (1990). Classification of cerebrovascular diseases III. Stroke, 21: 637-676.
21. OHENE-FREMPONG K., WEINER S.J., SLEEPER L.A., MILLER ST., EMBURY S., MOOHR J.W., WETHERS D.L., PEGELOW C.H., GILL F.M. and the Cooperative Study of Sickle Cell Disease (1998). Cerebrovascular accidents in Sickle Cell Disease: Rates and risk factors. Blood, 91: 288-294.
22. PEGELOW C.H., COTANGELA L., STEINBERG M., WRIGHT E.C., SMITH J., PHILLIPS G., VICHINSKY E. (1997). Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med, 102: 171-177.
23. PLATT O.S., BRAMBILLA D.J., ROSSE W.E., MILNER P.F., CASTRO O., STENBERG M.H., KLUG P.P. (1994). Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med, 330: 1639-1644.
24. POWARS D.R., WILSON B., IMBUS C., PEGELOW C., ALLEN J. (1978). The natural history of stroke in sickle cell disease. Am J Med, 65: 92-100.
25. POWARS D.R., MEISELMAN H.J., FISHER T.C., HITI A., JOHNSON C. (1994). Beta-S gene cluster haplotypes modulate hematologic and hemorhealogic expression in sickle cell anemia. Am J Pediatr Hematol Oncol, 16: 55-61.
26. QURESHI A.I., SURI M.A.K., SAFDAR K., OTTENLIPS J.R., JANSSEN R.S., FRANKEL M.R. (1997). Intracerebral Hemorrhage in Blacks. Risk factors, subtypes, and outcome. Stroke, 28: 961-964.
27. SCHWARTZ D. (1988). Méthodes statistiques appliquées à l'usage des médecins et des biologistes. Flammarion Médecine-Sciences.
28. SANDERCOCK P.A.G., WARLOW C.P., JONES L.N., STARKEY I.R. (1989). Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. Br Med J, 298: 75-79.
29. SEARS D.A. (1978). The morbidity of sickle cell trait. A review of litterature. Am J Med, 64: 1021-1031.
30. VERNANT J.C., DELAPORTE J.M., BUISSON R., BELLANCE R., BOKOR J., LOISEAU P. (1988). Complications cérébro-vasculaires de la drépanocytose. Rev Neurol, 144 : 465-473.
31. ZUBER M. et MAS J.L (1992), Épidemiologie des accidents vasculaires cérébraux. Rev Neural, 148: 243-255.